Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage

Biochemical and Biophysical Research Communications

Volumn 230, Issue 2, 1997, Pages 254-257

  Müller, Ingo ^a   Jenner, Andrew ^b   Bruchelt, Gernot ^a   Niethammer, Dietrich ^a   Halliwell, Barry ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; ANTHRACYCLINE DERIVATIVE; DNA; DNA BASE; DOXORUBICIN; MESSENGER RNA;

ACUTE LYMPHOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DNA MODIFICATION; DNA STRAND BREAKAGE; DRUG CYTOTOXICITY; DRUG MECHANISM; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; RNA SYNTHESIS;

EID: 0031566155     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.5898     Document Type: Article

References (22)

1. Pui C. H., Crist W. M. Curr. Opin. Oncol. 7:1995;36-44.
2. Chuang R. Y., Chuang L .F. Biochemistry. 18:1979;2069-2073.
3. Neidle S., Sanderson M. R. Molecular Aspects of Anti-Cancer Drug Action. 1983;Verlag Chemie, Weinheim. p. 35-53.
4. Cheng K. C., Cahill D. S., Kasai H., Nishimura S., Loeb L. A. J. Biol. Chem. 267:1992;166-172.
5. Ling Y.-H., Priebe W., Perez-Soler R. Cancer Res. 53:1993;1845-1852.
6. Friesen C., Herr I., Krammer P. H., Debatin K.-M. Nature Med. 2:1996;574-577.
7. Hannun Y. A., Obeid L. M. Trends Biol. Sci. 20:1995;73-77.
8. Buttke T. M., Sanstrom P. A. Immunol. Tod. 15:1994;7-10.
9. Hockenbery D., Oltvai Z. N., Yin X., Milliman C. L., Korsmeyer S. J. Cell. 75:1993;241-251.
10. Slater A. F., Nobel C. S., Orrenius S. Biochim. Biophys. Acta. 1271:1995;59-62.
11. Muschel R. J., Bernhard E. J., Garza L., McKenna W. G., Koch C. J. Cancer Res. 55:1995;995-998.
12. Jacobson M. D., Raff M. C. Nature. 374:1995;814-816.
13. Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H., Tsujimoto Y. Nature. 374:1995;811-813.
14. Jaffrèzou J.-P., Levade T., Bettaieb A., Andrieu N., Bezombes C., Maestre N., Vermeersch S., Rousse A., Laurent G. Embo J. 15:1996;2417-2424.
15. Bose R., Verheij M., Haimovitz-Friedmann A., Scotto K., Fuks Z., Kolesnick R. Cell. 82:1995;405-414.
16. Halliwell B., Bomford A. N. Engl. J. Med. 320:1989;399-400.
17. Fairbairn D. W., Olive P. L., O'Neill K. L. Mutation Res. 339:1995;37-59.
18. Spencer J. P. E., Jenner A., Chimel K., Aruoma O. I., Cross C. E., Wu R., Halliwell B. FEBS Lett. 374:1995;233-236.
19. Singh N. P., McCoy M. T., Tice R. R., Schneider E. L. Exp. Cell. Res. 175:1988;184-191.
20. Gedik C. M., Ewen S. W. B., Collins A. R. Int. J. Radiat. Biol. 62:1992;313-320.
21. Thakkar N. S., Potten C. S. Biochem. Pharmacol. 43:1992;1683-1691.
22. Gorczyca W., Bigman K., Mittelman A., Ahmed T., Gong J., Melamed M. R., Darzynkiewicz Z. Leukemia. 7:1993;659-670.